BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 1975167)

  • 1. New endocrine approaches to breast cancer.
    Howell A; Dodwell DJ; Anderson H
    Baillieres Clin Endocrinol Metab; 1990 Mar; 4(1):67-84. PubMed ID: 1975167
    [No Abstract]   [Full Text] [Related]  

  • 2. Novel approaches to the endocrine therapy of breast cancer.
    Dowsett M
    Eur J Cancer; 1990; 26(9):989-92. PubMed ID: 1980589
    [No Abstract]   [Full Text] [Related]  

  • 3. Differential effects of LHRH and somatostatin analogs on human breast cancer.
    Brower ST; Schally AV; Redding TW; Hollander VP
    J Surg Res; 1992 Jan; 52(1):6-14. PubMed ID: 1347798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocrine therapy of metastatic breast cancer.
    Manni A
    J Endocrinol Invest; 1989 May; 12(5):357-72. PubMed ID: 2570093
    [No Abstract]   [Full Text] [Related]  

  • 5. Steroid and peptide hormones and growth factors.
    Howell A; Wakeling AE
    Cancer Chemother Biol Response Modif; 1988; 10():117-28. PubMed ID: 3079380
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of carcinoma of the prostate with analogs of LHRH].
    Rubio Herrera MA; Calle Fernández JR
    Rev Clin Esp; 1986 Nov; 179(8):407-11. PubMed ID: 2951782
    [No Abstract]   [Full Text] [Related]  

  • 7. Novel endocrine therapies in breast cancer.
    Klijn JG; Setyono-Han B; Bontenbal M; Seynaeve C; Foekens J
    Acta Oncol; 1996; 35 Suppl 5():30-7. PubMed ID: 9142962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pituitary and gonadal effects of GnRH (gonadotropin releasing hormone) analogues in two peripubertal female rat models.
    Roth C; Hegemann F; Hildebrandt J; Balzer I; Witt A; Wuttke W; Jarry H
    Pediatr Res; 2004 Jan; 55(1):126-33. PubMed ID: 14605254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic manipulation of steroid hormones. Adjunctive therapies in cancer of the breast.
    Manni A
    Endocrinol Metab Clin North Am; 1991 Dec; 20(4):825-44. PubMed ID: 1778179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New hormonal therapies].
    Spielmann M
    Bull Cancer; 1994; 81(10 Suppl):8-10. PubMed ID: 7718951
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of growth of a prolactin-secreting pituitary tumor in rats by analogs of luteinizing hormone-releasing hormone and somatostatin.
    de Quijada MG; Redding TW; Coy DH; Torres-Aleman I; Schally AV
    Proc Natl Acad Sci U S A; 1983 Jun; 80(11):3485-8. PubMed ID: 6134284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the action of sex steroids by gonadotropin-releasing hormone (GnRH) agonists: a new biological effect.
    Sundaram K; Cao YQ; Wang NG; Bardin CW; Rivier J; Vale W
    Life Sci; 1981 Jan; 28(1):83-8. PubMed ID: 7012514
    [No Abstract]   [Full Text] [Related]  

  • 13. Direct effects of luteinizing hormone-releasing hormone agonists and antagonists on MCF-7 mammary cancer cells.
    Segal-Abramson T; Kitroser H; Levy J; Schally AV; Sharoni Y
    Proc Natl Acad Sci U S A; 1992 Mar; 89(6):2336-9. PubMed ID: 1312718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Luteinizing hormone-releasing hormone agonists for treatment of breast cancer].
    Gez E; Kovner F
    Harefuah; 1990 Jun; 118(11):655-8. PubMed ID: 2143745
    [No Abstract]   [Full Text] [Related]  

  • 15. Novel antitumor peptide hormones and their effect on signal transduction.
    Kéri G; Balogh A; Horváth A; Mezö I; Vadász Z; Bökönyi G; Bajor T; Vántus T; Teplán I; Horváth J
    J Steroid Biochem Mol Biol; 1992 Sep; 43(1-3):105-10. PubMed ID: 1356011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocrine treatment of advanced breast cancer.
    Dowsett M
    Acta Oncol; 1996; 35 Suppl 5():68-72. PubMed ID: 9142970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen deprivation in breast cancer. Clinical, experimental, and biological aspects.
    Nicholson RI; Walker KJ; Bouzubar N; Wills RJ; Gee JM; Rushmere NK; Davies P
    Ann N Y Acad Sci; 1990; 595():316-27. PubMed ID: 2142873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gonadotropin releasing hormone antagonists and cryopreservation outcome: a review.
    Nikolettos N; Asimakopoulos B; Simopoulou M; Al-Hasani S; Diedrich K
    Arch Gynecol Obstet; 2004 Sep; 270(2):69-73. PubMed ID: 14749941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse neurological symptoms after gonadotropin-releasing hormone analog therapy for in vitro fertilization cycles.
    Ashkenazi J; Goldman JA; Dicker D; Feldberg D; Goldman GA
    Fertil Steril; 1990 Apr; 53(4):738-40. PubMed ID: 2138573
    [No Abstract]   [Full Text] [Related]  

  • 20. Endocrine treatment of breast cancer.
    Ravdin PM
    Curr Ther Endocrinol Metab; 1994; 5():556-62. PubMed ID: 7704791
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.